Search
for
Sort by
Research 481–510 of 1000+
- Sex Hormones in COVID-19 Severity: The Quest for Evidence and Influence Mechanisms
- Diphenylcyclopropenone and platelet‐rich plasma in the management of severe or recalcitrant alopecia areata
- [Artículo traducido] Comparación entre la aplicación subcutánea vs. subcutánea e intramuscular combinada de toxina botulínica para el tratamiento de la alopecia androgenética: un ensayo clínico aleatorizado
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Therapeutic Potential of Brassinosteroids in Biomedical and Clinical Research
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Exploring novel management options for alopecia areata
- Iron–Skin Axis: Exploring the Interplay between Iron Homeostasis and Skin Disorders
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Recent Advances in the Pathogenesis of Autoimmune Hair Loss Disease Alopecia Areata
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Surface Engineered Metal-Organic Frameworks (MOFs) Based Novel Hybrid Systems for Effective Wound Healing: A Review of Recent Developments
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Chronic graft versus host disease and skin
- Pharmacological Efficacy of Tamarix aphylla: A Comprehensive Review
- Adaptive Triboelectric Nanogenerators for Long-Term Self-Treatment: A Review
- Post-COVID-19 syndrome among hospitalized COVID-19 patients: a cohort study assessing patients 6 and 12 months after hospital discharge
- Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial
- A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial
- Caesarean section versus vaginal birth in the perception of woman who gave birth by both methods
- Genetic Variants and Protective Immunity against SARS-CoV-2
- Southern African HIV Clinicians Society gender-affirming healthcare guideline for South Africa
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- Evaluating the effectiveness of laser hair reduction using a home use laser in comparison to a Diode laser